Hammond Power Solutions Inc. (HMDPF)

Achilles Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	27.86	34.09	52.59	28.13	20.91	14.8
Cash & Short-Term Investments	27.86	34.09	52.59	28.13	20.91	14.8
Cash Growth	-42.05%	-35.19%	86.98%	34.54%	41.30%	-36.70%
Accounts Receivable	157.52	123.57	112.47	77.99	67.57	49.36
Other Receivables	6.28	22.1	21.37	13.55	5.45	4.44
Receivables	163.8	145.67	133.84	91.54	73.03	53.8
Inventory	154.68	143.28	114.59	106.35	62.47	49.21
Prepaid Expenses	8.6	9.25	8.41	4.11	3.12	2.46
Other Current Assets	-	1.45	-	-	0.18	-
Total Current Assets	354.94	333.73	309.44	230.12	159.7	120.25
Property, Plant & Equipment	123.92	110.32	65.84	41.74	30.96	30.37
Long-Term Investments	2.6	-	-	-	13.28	13.3
Goodwill	15.34	16	11.74	12.02	12.22	10.91
Other Intangible Assets	12.42	13.73	6.59	7.65	10.5	5.9
Long-Term Accounts Receivable	-	-	-	-	2.78	3.2
Long-Term Deferred Tax Assets	14.03	13.97	11.8	8.01	2.37	1.81
Other Long-Term Assets	2.8	5.39	2.94	3.12	3.29	3.65
Total Assets	526.05	493.14	408.34	302.67	235.1	189.39
Accounts Payable	97.88	101.65	103.52	86.27	68.3	42.66
Accrued Expenses	23.24	32.45	21.71	5.76	2.35	1.36
Short-Term Debt	41.28	12.98	18.47	6.15	19.27	16.07
Current Portion of Leases	5.24	5.24	4.25	2.93	2.51	2.14
Current Income Taxes Payable	7.63	6.05	4.6	2.34	1.99	0.94
Current Unearned Revenue	3.15	4.28	5.72	10.61	5.03	0.2
Other Current Liabilities	3.87	4.83	7.2	3.63	2.56	3.76
Total Current Liabilities	182.27	167.48	165.47	117.68	101.99	67.15
Long-Term Leases	16.9	17.16	12.17	5.67	5.47	7.18
Long-Term Deferred Tax Liabilities	0	0	0.02	0.12	0.4	0.84
Other Long-Term Liabilities	0.44	0.45	0.31	2.32	1.24	0.32
Total Liabilities	199.61	185.1	177.97	125.78	109.1	75.48
Common Stock	15.76	15.76	15.76	15.24	14.89	14.49
Additional Paid-In Capital	2.29	2.29	2.29	2.38	2.43	2.5
Retained Earnings	296.67	263.62	203.7	146.85	106.58	95.41
Comprehensive Income & Other	11.71	26.37	8.63	12.43	2.11	1.52
Total Common Equity	326.44	308.04	230.38	176.89	126	113.92
Shareholders' Equity	326.44	308.04	230.38	176.89	126	113.92
Total Liabilities & Equity	526.05	493.14	408.34	302.67	235.1	189.39
Total Debt	63.41	35.39	34.89	14.75	27.25	25.39
Net Cash (Debt)	-35.55	-1.3	17.7	13.38	-6.34	-10.6
Net Cash Growth	-	-	32.29%	-	-	-
Net Cash Per Share	-2.99	-0.11	1.49	1.13	-0.54	-0.90
Filing Date Shares Outstanding	11.9	11.9	11.9	11.83	11.79	11.74
Total Common Shares Outstanding	11.9	11.9	11.9	11.83	11.79	11.74
Working Capital	172.66	166.24	143.97	112.45	57.71	53.11
Book Value Per Share	27.42	25.87	19.35	14.95	10.69	9.70
Tangible Book Value	298.68	278.3	212.05	157.22	103.28	97.11
Tangible Book Value Per Share	25.09	23.38	17.81	13.28	8.76	8.27
Land	-	4.59	4.35	4.18	4.2	4.21
Buildings	-	28.3	21.78	19.65	18.52	17.98
Machinery	-	126.77	88.2	83.03	67.11	65.52
Construction In Progress	-	16.63	16.04	3.04	4.35	2.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.